- Home
- CHDN vs BBIO Comparison
CHDN vs BBIO Comparison
Compare CHDN & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHDN
- BBIO
- Stock Information
- Founded
- CHDN 1928
- BBIO 2015
- Country
- CHDN United States
- BBIO United States
- Employees
- CHDN N/A
- BBIO N/A
- Industry
- CHDN Services-Misc. Amusement & Recreation
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- CHDN Consumer Discretionary
- BBIO Health Care
- Exchange
- CHDN Nasdaq
- BBIO Nasdaq
- Market Cap
- CHDN 7.1B
- BBIO 8.0B
- IPO Year
- CHDN N/A
- BBIO 2019
- Fundamental
- Price
- CHDN $105.30
- BBIO $43.40
- Analyst Decision
- CHDN Strong Buy
- BBIO Strong Buy
- Analyst Count
- CHDN 11
- BBIO 14
- Target Price
- CHDN $140.64
- BBIO $58.85
- AVG Volume (30 Days)
- CHDN 706.2K
- BBIO 3.3M
- Earning Date
- CHDN 07-23-2025
- BBIO 07-31-2025
- Dividend Yield
- CHDN 0.39%
- BBIO N/A
- EPS Growth
- CHDN 25.25
- BBIO N/A
- EPS
- CHDN 5.66
- BBIO N/A
- Revenue
- CHDN $2,786,000,000.00
- BBIO $127,415,000.00
- Revenue This Year
- CHDN $8.22
- BBIO $102.05
- Revenue Next Year
- CHDN $5.00
- BBIO $54.69
- P/E Ratio
- CHDN $18.60
- BBIO N/A
- Revenue Growth
- CHDN 11.75
- BBIO N/A
- 52 Week Low
- CHDN $85.58
- BBIO $21.72
- 52 Week High
- CHDN $150.21
- BBIO $45.48
- Technical
- Relative Strength Index (RSI)
- CHDN 68.77
- BBIO 63.17
- Support Level
- CHDN $100.35
- BBIO $41.80
- Resistance Level
- CHDN $100.80
- BBIO $45.48
- Average True Range (ATR)
- CHDN 2.05
- BBIO 1.51
- MACD
- CHDN 0.70
- BBIO -0.08
- Stochastic Oscillator
- CHDN 97.05
- BBIO 63.36
About CHDN Churchill Downs Incorporated
Churchill Downs Inc is a gaming entertainment, online wagering, and racing company. It operates through three business segments: Live and Historical Racing, Wagering Services, and Gaming. The Live and Historical Racing segment includes live and historical pari-mutuel racing. The Wagering Services segment includes the revenue and expenses from pari-mutuel wagers through TwinSpires, companies retail and online sports betting business and Gaming segment includes revenue and expenses for the casino properties and associated racetracks that support the casino license. The Gaming segment generates revenue and expenses from slot machines, video lottery terminals, video poker, HRMs, ancillary food and beverage services, hotel services, commission on pari-mutuel wagering, and racing events.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.